PMC:7352545 / 64512-64820 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T619","span":{"begin":36,"end":38},"obj":"Body_part"},{"id":"T620","span":{"begin":48,"end":50},"obj":"Body_part"},{"id":"T621","span":{"begin":113,"end":125},"obj":"Body_part"},{"id":"T622","span":{"begin":144,"end":146},"obj":"Body_part"},{"id":"T623","span":{"begin":221,"end":233},"obj":"Body_part"},{"id":"T624","span":{"begin":270,"end":272},"obj":"Body_part"}],"attributes":[{"id":"A619","pred":"fma_id","subj":"T619","obj":"http://purl.org/sig/ont/fma/fma273565"},{"id":"A620","pred":"fma_id","subj":"T620","obj":"http://purl.org/sig/ont/fma/fma273565"},{"id":"A621","pred":"fma_id","subj":"T621","obj":"http://purl.org/sig/ont/fma/fma62925"},{"id":"A622","pred":"fma_id","subj":"T622","obj":"http://purl.org/sig/ont/fma/fma273565"},{"id":"A623","pred":"fma_id","subj":"T623","obj":"http://purl.org/sig/ont/fma/fma62925"},{"id":"A624","pred":"fma_id","subj":"T624","obj":"http://purl.org/sig/ont/fma/fma273565"}],"text":"SARS-CoV uses the C-type lectins of DC-SIGN and DC-L-SIGN as additional or secondary receptors. Glycans on the S glycoprotein are recognized by DC/L-SIGN for virus attachment and entry. Seven glycosylation sites of the S glycoprotein have been found to be essential for DC/L-SIGN-driven virus entry [86,130]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T254","span":{"begin":0,"end":8},"obj":"Disease"}],"attributes":[{"id":"A254","pred":"mondo_id","subj":"T254","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"SARS-CoV uses the C-type lectins of DC-SIGN and DC-L-SIGN as additional or secondary receptors. Glycans on the S glycoprotein are recognized by DC/L-SIGN for virus attachment and entry. Seven glycosylation sites of the S glycoprotein have been found to be essential for DC/L-SIGN-driven virus entry [86,130]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T925","span":{"begin":36,"end":38},"obj":"http://purl.obolibrary.org/obo/CL_0000451"},{"id":"T926","span":{"begin":48,"end":50},"obj":"http://purl.obolibrary.org/obo/CL_0000451"},{"id":"T927","span":{"begin":144,"end":146},"obj":"http://purl.obolibrary.org/obo/CL_0000451"},{"id":"T928","span":{"begin":158,"end":163},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T929","span":{"begin":270,"end":272},"obj":"http://purl.obolibrary.org/obo/CL_0000451"},{"id":"T930","span":{"begin":287,"end":292},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"SARS-CoV uses the C-type lectins of DC-SIGN and DC-L-SIGN as additional or secondary receptors. Glycans on the S glycoprotein are recognized by DC/L-SIGN for virus attachment and entry. Seven glycosylation sites of the S glycoprotein have been found to be essential for DC/L-SIGN-driven virus entry [86,130]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T43310","span":{"begin":113,"end":125},"obj":"Chemical"},{"id":"T33261","span":{"begin":221,"end":233},"obj":"Chemical"}],"attributes":[{"id":"A89794","pred":"chebi_id","subj":"T43310","obj":"http://purl.obolibrary.org/obo/CHEBI_17089"},{"id":"A33102","pred":"chebi_id","subj":"T33261","obj":"http://purl.obolibrary.org/obo/CHEBI_17089"}],"text":"SARS-CoV uses the C-type lectins of DC-SIGN and DC-L-SIGN as additional or secondary receptors. Glycans on the S glycoprotein are recognized by DC/L-SIGN for virus attachment and entry. Seven glycosylation sites of the S glycoprotein have been found to be essential for DC/L-SIGN-driven virus entry [86,130]."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T110","span":{"begin":192,"end":205},"obj":"http://purl.obolibrary.org/obo/GO_0070085"}],"text":"SARS-CoV uses the C-type lectins of DC-SIGN and DC-L-SIGN as additional or secondary receptors. Glycans on the S glycoprotein are recognized by DC/L-SIGN for virus attachment and entry. Seven glycosylation sites of the S glycoprotein have been found to be essential for DC/L-SIGN-driven virus entry [86,130]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T622","span":{"begin":0,"end":95},"obj":"Sentence"},{"id":"T623","span":{"begin":96,"end":185},"obj":"Sentence"},{"id":"T624","span":{"begin":186,"end":308},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"SARS-CoV uses the C-type lectins of DC-SIGN and DC-L-SIGN as additional or secondary receptors. Glycans on the S glycoprotein are recognized by DC/L-SIGN for virus attachment and entry. Seven glycosylation sites of the S glycoprotein have been found to be essential for DC/L-SIGN-driven virus entry [86,130]."}

{"project":"2_test","denotations":[{"id":"32604730-15479853-51944095","span":{"begin":300,"end":302},"obj":"15479853"},{"id":"32604730-17715238-51944096","span":{"begin":303,"end":306},"obj":"17715238"},{"id":"T44225","span":{"begin":300,"end":302},"obj":"15479853"},{"id":"T48656","span":{"begin":303,"end":306},"obj":"17715238"}],"text":"SARS-CoV uses the C-type lectins of DC-SIGN and DC-L-SIGN as additional or secondary receptors. Glycans on the S glycoprotein are recognized by DC/L-SIGN for virus attachment and entry. Seven glycosylation sites of the S glycoprotein have been found to be essential for DC/L-SIGN-driven virus entry [86,130]."}